CoChat
Sign Up
Cited by 17Drug Transport and Resistance MechanismsBiochemical Acid Research StudiesAlcoholism and Thiamine Deficiency

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Substrate transport and drug interaction of human thiamine transporters SLC19A2/A3

Open access
Li, Peipei, Zhu, Zhini, Wang, Yong, Zhang, Xuyuan, Yang, Chuanhui, Zhu, Yalan, Zhou, Zixuan, Chao, Yulin, Long, Yonghui, Gao, Yina, Liu, Songqing, Zhang, Liguo, Gao, Pu, Qu, Qianhui·2024·Nature Communications
DOI 10.1038/s41467-024-55359-8PMC PMC11686366

Published version of a preprint

Open this paper in CoChat — free accountOpen PDF

Abstract

Thiamine and pyridoxine are essential B vitamins that serve as enzymatic cofactors in energy metabolism, protein and nucleic acid biosynthesis, and neurotransmitter production. In humans, thiamine transporters SLC19A2 and SLC19A3 primarily regulate cellular uptake of both vitamins. Genetic mutations in these transporters, which cause thiamine and pyridoxine deficiency, have been implicated in severe neurometabolic diseases. Additionally, various prescribed medicines, including metformin and fedratinib, manipulate thiamine transporters, complicating the therapeutic effect. Despite their physiological and pharmacological significance, the molecular underpinnings of substrate and drug recognition remain unknown. Here we present ten cryo-EM structures of human thiamine transporters SLC19A3 and SLC19A2 in outward- and inward-facing conformations, complexed with thiamine, pyridoxine, metformin, fedratinib, and amprolium. These structural insights, combined with functional characterizations, illuminate the translocation mechanism of diverse chemical entities, and enhance our understanding of drug-nutrient interactions mediated by thiamine transporters.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-024-55359-8

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 62

  1. Institute of Medicine (US) Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline. Dietary Reference Intakes for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin, and Choline. (National Academies Press (US), Washington (DC), 1998).
  2. Brown, G. & Plecko, B. Disorders of Thiamine and Pyridoxine Metabolism. in Inborn Metabolic Diseases: Diagnosis and Treatment (eds. Saudubray, J.-M., Baumgartner, M. R., García-Cazorla, Á. & Walter, J.) 531–545 (Springer, Berlin, Heidelberg, 2022). https://doi.org/10.1007/978-3-662-63123-2_29. · DOI
  3. Fattal-Valevski, A. Thiamine (Vitamin B1). J. Evid. -Based Complement. Altern. Med. 16, 12–20 (2011). · DOI
  4. Calderón-Ospina, C. A. & Nava-Mesa, M. O. B Vitamins in the nervous system: Current knowledge of the biochemical modes of action and synergies of thiamine, pyridoxine, and cobalamin. CNS Neurosci. Ther. 26, 5–13 (2020). · DOI
  5. Dutta, B. et al. Cloning of the human thiamine transporter, a member of the folate transporter. Fam. *. J. Biol. Chem. 274, 31925–31929 (1999). · DOI
  6. Rajgopal, A., Edmondnson, A., Goldman, I. D. & Zhao, R. SLC19A3 encodes a second thiamine transporter ThTr2. Biochim. Biophys. Acta 1537, 175–178 (2001). · DOI
  7. Yamashiro, T., Yasujima, T., Said, H. M. & Yuasa, H. pH-dependent pyridoxine transport by SLC19A2 and SLC19A3: Implications for absorption in acidic microclimates. J. Biol. Chem. 295, 16998–17008 (2020). · DOI
  8. Eudy, J. D. et al. Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes. Mol. Genet. Metab. 71, 581–590 (2000). · DOI
  9. Labay, V. et al. Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. Nat. Genet. 22, 300–304 (1999). · DOI
  10. Oishi, K. et al. Targeted disruption of Slc19a2, the gene encoding the high-affinity thiamin transporter Thtr-1, causes diabetes mellitus, sensorineural deafness and megaloblastosis in mice. Hum. Mol. Genet. 11, 2951–2960 (2002). · DOI
  11. Kono, S. et al. Mutations in a thiamine-transporter gene and Wernicke’s-like encephalopathy. N. Engl. J. Med. 360, 1792–1794 (2009). · DOI
  12. Wang, J. et al. Report of the largest Chinese Cohort With SLC19A3 gene defect and literature review. Front. Genet. 12, 683255 (2021). · DOI
  13. Alfadhel, M. et al. Targeted SLC19A3 gene sequencing of 3000 Saudi newborn: a pilot study toward newborn screening. Ann. Clin. Transl. Neurol. 6, 2097–2103 (2019). · DOI
  14. Zeng, W.-Q. et al. Biotin-responsive Basal Ganglia Disease Maps to 2q36.3 and is due to mutations in SLC19A3. Am. J. Hum. Genet. 77, 16–26 (2005). · DOI
  15. Reidling, J. C., Lambrecht, N., Kassir, M. & Said, H. M. Impaired Intestinal Vitamin B1 (Thiamin) uptake in Thiamin Transporter-2–deficient mice. Gastroenterology 138, 1802–1809 (2010). · DOI
  16. Wen, A. et al. The impacts of Slc19a3 deletion and intestinal SLC19A3 insertion on Thiamine distribution and brain metabolism in the mouse. Metabolites 13, 885 (2023). · DOI
  17. Neufeld, E. J., Fleming, J. C., Tartaglini, E. & Steinkamp, M. P. Thiamine-responsive megaloblastic anemia syndrome: a disorder of high-affinity thiamine transport. Blood Cells Mol. Dis. 27, 135–138 (2001). · DOI
  18. Chen, L. et al. OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin. Proc. Natl Acad. Sci. 111, 9983–9988 (2014). · DOI
  19. Liang, X. et al. Metformin Is a substrate and inhibitor of the human thiamine Transporter, THTR-2 (SLC19A3). Mol. Pharm. 12, 4301–4310 (2015). · DOI
  20. Zhang, Q. et al. The Janus Kinase 2 Inhibitor Fedratinib inhibits Thiamine uptake: a putative mechanism for the onset of Wernicke’s Encephalopathy. Drug Metab. Dispos. 42, 1656–1662 (2014). · DOI
  21. Vora, B. et al. Drug–nutrient interactions: discovering prescription drug inhibitors of the thiamine transporter ThTR-2 (SLC19A3). Am. J. Clin. Nutr. 111, 110–121 (2020). · DOI
  22. Giacomini, M. M. et al. Interaction of 2,4-Diaminopyrimidine-containing drugs including Fedratinib and Trimethoprim with Thiamine transporters. Drug Metab. Dispos. Biol. Fate Chem. 45, 76–85 (2017). · DOI
  23. McGarvey, C., Franconi, C., Prentice, D. & Bynevelt, M. Metformin-induced encephalopathy: the role of thiamine. Intern. Med. J. 48, 194–197 (2018). · DOI
  24. Ziegler, D., Reiners, K., Strom, A. & Obeid, R. Association between diabetes and thiamine status - A systematic review and meta-analysis. Metab Clin. Exp. 144, 155565 (2023). · DOI
  25. Drew, D., North, R. A., Nagarathinam, K. & Tanabe, M. Structures and general transport mechanisms by the Major Facilitator Superfamily (MFS). Chem. Rev. 121, 5289–5335 (2021). · DOI
  26. Yan, N. Structural biology of the major facilitator superfamily transporters. Annu. Rev. Biophys. 44, 257–283 (2015). · DOI
  27. Zhang, Q. et al. Recognition of cyclic dinucleotides and folates by human SLC19A1. Nature 612, 170–176 (2022). · DOI
  28. Wright, N. J. et al. Methotrexate recognition by the human reduced folate carrier SLC19A1. Nature 609, 1056–1062 (2022). · DOI
  29. Dang, Y. et al. Molecular mechanism of substrate recognition by folate transporter SLC19A1. Cell Discov. 8, 1–11 (2022). · DOI · Paper page
  30. McIlwain, B. C. et al. N-terminal Transmembrane-Helix Epitope Tag for X-ray crystallography and electron microscopy of small membrane proteins. J. Mol. Biol. 433, 166909 (2021). · DOI
  31. Subramanian, V. S., Marchant, J. S., Parker, I. & Said, H. M. Cell Biology of the Human Thiamine Transporter-1 (hTHTR1): Intracellular trafficking and membrane targeting mechanisms * 210. J. Biol. Chem. 278, 3976–3984 (2003). · DOI
  32. Blair, H. A. Fedratinib: First approval. Drugs 79, 1719–1725 (2019). · DOI
  33. Meyer, M. J. et al. Differences in Metformin and Thiamine uptake between human and mouse organic Cation Transporter 1: Structural determinants and potential consequences for intrahepatic concentrations. Drug Metab. Dispos. 48, 1380–1392 (2020). · DOI
  34. Zeng, Y. C. et al. Structural basis of promiscuous substrate transport by Organic Cation Transporter 1. Nat. Commun. 14, 6374 (2023). · DOI
  35. Dudeja, P. K., Tyagi, S., Kavilaveettil, R. J., Gill, R. & Said, H. M. Mechanism of thiamine uptake by human jejunal brush-border membrane vesicles. Am. J. Physiol. Cell Physiol. 281, C786–C792 (2001). · DOI
  36. Wesół-Kucharska, D. et al. Early treatment of biotin–thiamine–responsive basal ganglia disease improves the prognosis. Mol. Genet. Metab. Rep. 29, 100801 (2021).
  37. Godo, S. et al. The dramatic recovery of a patient with biguanide-associated severe lactic acidosis following thiamine supplementation. Intern. Med. 56, 455–459 (2017). · DOI
  38. Gabriel, F. et al. Structural basis of substrate transport and drug recognition by the human thiamine transporter SLC19A3. Nat. Commun. 15, 8542 (2024). · DOI
  39. Dang, Y. et al. Substrate and drug recognition mechanisms of SLC19A3. Cell Res. 1–4 https://doi.org/10.1038/s41422-024-00951-2 (2024). · DOI
  40. Zhang, X. et al. The binding of a monoclonal antibody to the apical region of SCARB2 blocks EV71 infection. Protein Cell 8, 590–600 (2017). · DOI
  41. Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51 (2005). · DOI
  42. Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods 14, 331–332 (2017). · DOI
  43. Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017). · DOI · Paper page
  44. Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife 7, e42166 (2018). · DOI
  45. Ef, P. et al. UCSF Chimera--a visualization system for exploratory research and analysis. J. Comput. Chem. 25 https://pubmed.ncbi.nlm.nih.gov/15264254/ (2004). · DOI
  46. Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486–501 (2010). · DOI · Paper page
  47. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66, 213–221 (2010). · DOI · Paper page
  48. Moriarty, N. W., Grosse-Kunstleve, R. W. & Adams, P. D. electronic Ligand Builder and Optimization Workbench (eLBOW): a tool for ligand coordinate and restraint generation. Acta Crystallogr. D. Biol. Crystallogr. 65, 1074–1080 (2009). · DOI
  49. Goddard, T. D. et al. UCSF ChimeraX: Meeting modern challenges in visualization and analysis. Protein Sci. Publ. Protein Soc. 27, 14–25 (2018). · DOI · Paper page
  50. Shelley, J. C. et al. Epik: a software program for pKaprediction and protonation state generation for drug-like molecules. J. Comput. Aided Mol. Des. 21, 681–691 (2007). · DOI
  51. Harder, E. et al. OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. J. Chem. Theory Comput. 12, 281–296 (2016). · DOI
  52. Halgren, T. A. et al. Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750–1759 (2004). · DOI
  53. Olsson, M. H. M., Søndergaard, C. R., Rostkowski, M. & Jensen, J. H. PROPKA3: Consistent treatment of internal and surface residues in empirical pKa predictions. J. Chem. Theory Comput. 7, 525–537 (2011). · DOI
  54. Wu, E. L. et al. CHARMM-GUI Membrane Builder toward realistic biological membrane simulations. J. Comput. Chem. 35, 1997–2004 (2014). · DOI
  55. Huang, J. et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins. Nat. Methods 14, 71–73 (2017). · DOI
  56. Abraham, M. J. et al. GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers. SoftwareX 1, 19–25 (2015). · DOI · Paper page
  57. Steinbach, P. J. & Brooks, B. R. New spherical-cutoff methods for long-range forces in macromolecular simulation. J. Comput. Chem. 15, 667–683 (1994). · DOI
  58. Hess, B. P-LINCS: A parallel linear constraint solver for molecular simulation. J. Chem. Theory Comput. 4, 116–122 (2008). · DOI
  59. Bussi, G., Donadio, D. & Parrinello, M. Canonical sampling through velocity rescaling. J. Chem. Phys. 126, 014101 (2007). · DOI
  60. Godschalk, F., Genheden, S., Söderhjelm, P. & Ryde, U. Comparison of MM/GBSA calculations based on explicit and implicit solvent simulations. Phys. Chem. Chem. Phys. 15, 7731–7739 (2013). · DOI
  61. Valdés-Tresanco, M. S., Valdés-Tresanco, M. E., Valiente, P. A. & Moreno, E. gmx_MMPBSA: A new tool to perform end-state free energy calculations with GROMACS. J. Chem. Theory Comput. https://doi.org/10.1021/acs.jctc.1c00645 (2021). · DOI
  62. Bill R. Miller, I. I. I. et al. MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. ACS Publications https://pubs.acs.org/doi/abs/10.1021/ct300418h (2012). · DOI

Metadata

Authors
Li, P., Zhu, Z., Wang, Y., Zhang, X., Yang, C., Zhu, Y., Zhou, Z., Chao, Y., Long, Y., Gao, Y., Liu, S., Zhang, L., Gao, P., & Qu, Q.
Affiliations
  • Shanghai Medical College of Fudan University (CN)
  • Chinese Academy of Sciences (CN)
  • Beijing Institute of Technology (CN)
Corresponding author
  • Wang, Yong
  • Zhang, Liguo
  • Gao, Pu
  • Qu, Qianhui
ORCID
Venue
Nature Communications
Publisher
Springer Science and Business Media LLC
Published
2024-12-30
Volume
15
Issue
1
Pages
10924-10924
ISSN
2041-1723 (ISSN-L)
DOI
10.1038/s41467-024-55359-8
PMC
PMC11686366
OpenAlex
W4405895626
Cited by
17
References
1
Citations by year
2026: 7 · 2025: 10
FWCI
2.91
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by-nc-nd)
  • Research Square (acceptedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
National Natural Science Foundation of China (32371256)
Topics
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Biochemical Acid Research Studies
  • Health Sciences › Medicine › Clinical Neurology › Alcoholism and Thiamine Deficiency
Keywords
thiamine transporter, SLC19A2, SLC19A3, thiamine, pyridoxine, B vitamins, drug-nutrient interactions, metformin, fedratinib, amprolium, transporter conformational change, substrate recognition, translocation mechanism, cryo-EM structure, thiamine deficiency, vitamin B6 deficiency, neurometabolic disorders
MeSH terms
Biological Transport, Humans, Metformin, Models, Molecular, Pyridoxine, Pyrrolidines, Thiamine, Cryoelectron Microscopy, Membrane Transport Proteins, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review